DPP4 and type 1 diabetes mellitus: Based on the pooled data in our meta-analysis, treatment with DPP-4 inhibitors neither resulted in a significantly greater decrease in the HbA1c levels nor further reduced the insulin dosage or affected the weight or BMI in patients with T1DM.